Funder: American Brain Tumor Association
Due Dates (Anticipated): December 2027 (LOI) | March 2028 (Full application)
Funding Amounts: Up to $200,000 in direct costs over two years
Summary: Supports multidisciplinary, inter-institutional teams pursuing high-risk, high-impact research to improve brain tumor diagnosis and treatment.
Key Information: Lead PIs must be early-career faculty at nonprofit, non-governmental institutions in the United States or Canada.
Description
The American Brain Tumor Association’s Research Collaboration Grants support teams of two faculty investigators at different institutions. The program promotes team science through multidisciplinary, high-risk/high-impact projects that could change diagnostic or treatment paradigms for adult and pediatric brain tumor care. It also supports early scientific studies needed to secure future funding for collaborative research.
Projects may address any brain tumor type, including benign, malignant, primary, and secondary (metastatic) tumors. Relevant areas include biomarkers, brain tumor biology, clinical research, diagnosis, drug delivery, etiology, genetics, imaging, molecular/genetic epidemiology, novel therapeutics, and risk assessment. Projects should combine components such as basic, translational, clinical, and epidemiological research. Investigators from sciences outside traditional biological fields are encouraged to apply.
